Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

251 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

NCT05568706

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Voyage Medical Tempe, Arizona, United States
  • UCSF Fresno Fresno, California, United States
  • Torrance Clinical Research Institute Lomita, California, United States
  • Downtown LA Research Center Inc - ClinEdge - PPDS Los Angeles, California, United States
View all 84 locations
View Trial Details
Completed

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

NCT06573281

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Omaha, Nebraska, United States
View Trial Details
Completed

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age

NCT04520659

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • John Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

NCT06614725

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Kanpur, Uttar Pradesh, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Aligarh, India
View all 14 locations
View Trial Details
Completed

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

NCT05268939

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Diagnamics, Inc Encinitas, California, United States
  • Marisela Gonzalez, MD, PA Miami, Florida, United States
  • Excellence Medical and Research Miami Gardens, Florida, United States
View Trial Details
Completed

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

NCT04782336

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +19 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Lothian - Royal Hospital for Children & Young People Edinburgh, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Barts Health NHS Trust London, United Kingdom
View Trial Details
Completed

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921

Conditions
Infections, Influenza, Human, Mononegavirales Infections, +8 more
Locations
  • MedHelp Urgent Care Birmingham, Alabama, United States
  • Access Medical Center Encinitas, California, United States
  • Madera Family Medical Group Madera, California, United States
  • ImmunoE Health and Research Centennial, Colorado, United States
View all 20 locations
View Trial Details

Related conditions